1. Danielewski O., Schultess J., Smolenski A.: The NO/cGMP pathway inhibits Rap 1 activation in human platelets via cGMP-dependent protein kinase I. Thromb. Haemost., 2005, 93, 319-325.
2. Fisher N.D.L., Hughes M., Gerhard-Herman M., Hollenberg N.K.: Flawonol-rich cocoa induces nitric oxide-dependent vasodilatation in healthy humans. J. Hypertens., 2003, 21, 2281-2286.
3. Geleijnse J.M., Launer I.J., Hofman A., et al.: Tea flawonoids may protect against atherosclerosis: The Rotterdam Study. Arch. Intern. Med., 1999, 159, 2170-2174.
4. Heiss C., Dejam A., Kleinbongard P., et al.: Vascular effects of cocoa rich in flavan-3-ols. J. Am. Med. Assoc., 2003, 20, 1030-1031.
5. Hercberg S., Preziosi P., Galan P., et al.: The SUVIMAX Study: a primary prevention trial using nutritional doses of antioxidant vitamins and minerals in cardiovascular diseases and cancers. Supplementation on VItamines et Mineraux AntioXydants. Food Chem Toxicol., 1999, 37, 925-30.
6. Hertog M.G., Feskens E.J., Hollman P.C., et al.: Dietary antioxidant flawonoids and risk of coronary heart disease. The Zutphen Elderly Study. Lancet 1993, 342, 1007-1011.
7. Hertog M.G., Kromhout D., Aravanis C., et al.: Flawonoid intake and long-term risk of coronary heart disease and cancer in the Seven Countries Study. Arch. Intern. Med., 1995, 155, 381-386.
8. Hollenberg N.K., Rivera A., Meinking T., et al.: Age, renal perfusion, and function in island-dwelling indigenous Kuna Amerinds in Panama. Nephron 1999, 82, 131-138.
10. Knekt P., Jarvinen R., Reunanen A., Mastela J.: Flawonoid intake and coronary mortality in Finland. Brit. Med. J., 1996, 312, 478-481.
11. Liwei G., Kelm M.A., Hammerstone J.F., et al.: Concentrations of proanthocyanidins in common foods and estimations of normal consumption. J. Nutr., 2004, 134, 613-617.
12. Mukamal K.J., Maclure M., Muller J.E., et al.: Tea consumption and mortality after acute myocardial infarction. Circulation 2002, 105, 2476-2481.
13. New S.A., Robins S.P., Campbell M.K., et al.: Dietary influences on bone mass and bone metabolism: further evidence of a positive link between fruit and vegetable consumption and bone health? Am. J. Clin. Nutr., 2000, 71, 142-51.
14. Pearson D., Holt R.R., Rein D., et al.: Flawonols and platelet reactivity. Clin. Dev. Immunol., 2005, 12, 1-9.
15. Rein D., Paglieroni T.G., Pearson D.A., et al.: Cocoa inhibits platelet activation and function. Am. J. Clin. Nutr., 2000, 72, 30-35.
16. Schewe T., Kuhn H., Sies H.: Flawonoids of cocoa inhibit recombinant human 5-lipooxygenase. J. Nutr., 2002, 132, 1825-1829.
17. Steffen Y., Schewe T., Sies H.: Epicatechin protects endothelial cells against oxidized LDL and maintains NO synthase. Biochem. Biophys. Res. Coommun., 2005, 331, 1277-1283.
18. Stensvold I., Tverdal, A., Solvoll K., et al.: Tea consumption: relationship to cholesterol, blood pressure, and coronary and total mortality. Prev. Med., 1992, 21, 546-553.
19. Taubert D., Berkels R., Roesen R., Klaus W.: Chocolate and blood pressure in elderly individuals with isolated systolic hypertension. J. Am. Med. Assoc., 2003, 290, 8, 1029-1030.
20. Wallerath T., Li H., Dodtel-Ambrust U., et al.: A blend of polyphenolic compounds explains the stimulatory effect of red wine on human endothelial NO synthase. Nitric Oxide 2005, 12, 97-104.
21. Wiswedel I., Hirsch D., Kropf S., et al.: Flavonol-rich cocoa drink lowers plasma F2-isoprostane concentrations in humans. Free Radic. Biol. Med., 2004, 37, 411-421.
22. Yochum L., Kushi L.H., Meyer K., Folsom A.R.: Dietary flawonoid intake and risk of cardiovascular disease in postmenopausal women. Am. J. Epidemiol., 1999, 149, 943-949.